Houssein Safa, MD (@hsafamd) 's Twitter Profile
Houssein Safa, MD

@hsafamd

Heme/Onc fellow @BCMHouston @BCMHemeonc. Postdoc alumnus via @MDandersonnews. A ♋️ treating cancer. Despiser of windowless rooms. Views are my own.

ID: 264227837

linkhttp://bit.ly/2Kc9c1M calendar_today11-03-2011 15:15:34

2,2K Tweet

3,3K Followers

900 Following

Houssein Safa, MD (@hsafamd) 's Twitter Profile Photo

I remain a firm believer that if your stable patient is asleep during pre-rounds, please don’t wake them up. Deep sleep is a very rare precious commodity during hospitalization, let them have it.

Houssein Safa, MD (@hsafamd) 's Twitter Profile Photo

Petition to replace mandatory wellness modules with Epic EMR “useful tricks” modules. Did y’all know you could type in “trend [insert requested variable]” in the search bar and Epic will automatically create a graph with all historical values? 🤯

Talal El Zarif, MD (@talalzarif1) 's Twitter Profile Photo

🚨Out now Clinical Cancer Research! We demonstrate accurate non-invasive detection of small cell transformation in EGFRm lung adenocarcinoma through epigenomic cfDNA profiling! Led by @Cbmeador Xintao & guided by Jacob Berchuck #MattFreedman Dana-Farber Mass General Cancer Center doi.org/10.1158/1078-0…

🚨Out now <a href="/CCR_AACR/">Clinical Cancer Research</a>! We demonstrate accurate non-invasive detection of small cell transformation in EGFRm lung adenocarcinoma through epigenomic cfDNA profiling! Led by @Cbmeador <a href="/Xintao_Qiu/">Xintao</a> &amp; guided by <a href="/jberchuck/">Jacob Berchuck</a> #MattFreedman <a href="/DanaFarber/">Dana-Farber</a> <a href="/MGHCancerCenter/">Mass General Cancer Center</a> doi.org/10.1158/1078-0…
BCM Hematology-Oncology Fellowship (@bcmhemeonc) 's Twitter Profile Photo

Even in a busy Monday heme clinic, our fellows and attendings find a moment to pose for photos! We’re so proud of our freshly minted PGY-4, Houssein Safa, MD, for winning one of the Fellows of the Quarter awards. Come join our fellowship we promise to recognize all your achievements!

BCM Hematology-Oncology Fellowship (@bcmhemeonc) 's Twitter Profile Photo

It's true that we just said goodbye to our graduating fellows, but we also welcomed a new wonderful class of 11 fellows! Excited to see how these bright minds make cancer history. Say hi to the Class of 2027! BCMHouston

It's true that we just said goodbye to our graduating fellows, but we also welcomed a new wonderful class of 11 fellows! Excited to see how these bright minds make cancer history. Say hi to the Class of 2027! <a href="/bcmhouston/">BCMHouston</a>
Houssein Safa, MD (@hsafamd) 's Twitter Profile Photo

What a great way to warm things up as the season approaches .. Applying to the upcoming or any future heme/onc match? Give this post a chance 👇🏻 and tell your friends!

Martha Mims (@marthamims) 's Twitter Profile Photo

First journal club of the year- fabulous presentation by Lynne Cook- liver transplant in metastatic colon cancer. Great debate- great company and great food! Amazing BCM fellows

First journal club of the year- fabulous presentation by Lynne Cook- liver transplant in metastatic colon cancer.  Great debate- great company and great food!  Amazing BCM fellows
Houssein Safa, MD (@hsafamd) 's Twitter Profile Photo

Do u acknowledge the person who brings your patient to their visit? The spouse, the child, the friend, the one who rearranged their life to be there? A greeting. A nod. A question. It costs nothing but means everything. Why do we so often ignore them? Let’s talk about it. 👇

Houssein Safa, MD (@hsafamd) 's Twitter Profile Photo

Getting invited by a medical journal to share your expert opinion only to be charged thousands to publish it is like asking a surgeon to perform a free transplant and then billing them for the OR. Am I right?

jc (@jadchahoud) 's Twitter Profile Photo

‼️🚨A Contemporary Review on Immune-Based and Novel Therapies in Variant Histology Renal Cell Carcinomas by ⭐️⁦Moffitt Hematology/Oncology Fellowship⁩ ⁦Justin Miller⁩ #JeffJhonson ⁦Chris Guske⁩ ⁦Moffitt Cancer Center⁩ mdpi.com/2072-6694/17/2…

Neeraj Agarwal, MD, FASCO (@neerajaiims) 's Twitter Profile Photo

Ab#4515 ASCO #ASCO25 by jc 👉 bit.ly/45mJSAV👉Phase 1b STELLAR-002 study of zanzalintinib + nivo +/- relatlimab in pts w/ ccRCC #kidneycancer 👉ORR 63% w/ zanza+nivo & 33% w/ zanza+nivo/rela w/ acceptable tolerability👇#NeilShah OncoAlert UroToday.com @KidneyCAN

Ab#4515 <a href="/ASCO/">ASCO</a> #ASCO25 by <a href="/JadChahoud/">jc</a> 👉 bit.ly/45mJSAV👉Phase 1b STELLAR-002 study of zanzalintinib + nivo +/- relatlimab in pts w/ ccRCC #kidneycancer 👉ORR 63% w/ zanza+nivo &amp; 33% w/ zanza+nivo/rela w/ acceptable tolerability👇#NeilShah <a href="/OncoAlert/">OncoAlert</a> <a href="/urotoday/">UroToday.com</a> @KidneyCAN
Neeraj Agarwal, MD, FASCO (@neerajaiims) 's Twitter Profile Photo

Congrats @jadchahoud on the terrific talk👉Ab#4515 ASCO #ASCO25 👉Phase 1b STELLAR-002 study of zanzalintinib + nivo +/- relatlimab in pts w/ ccRCC #kidneycancer 👉ORR 63% w/ zanza+nivo (adding relatlimab does not help), key takeaway👇 OncoAlert UroToday.com @KidneyCAN Sumanta K. Pal, MD, FASCO

Congrats @jadchahoud on the terrific talk👉Ab#4515 <a href="/ASCO/">ASCO</a> #ASCO25 👉Phase 1b STELLAR-002 study of zanzalintinib + nivo +/- relatlimab in pts w/ ccRCC #kidneycancer 👉ORR 63% w/ zanza+nivo (adding relatlimab does not help), key takeaway👇 <a href="/OncoAlert/">OncoAlert</a> <a href="/urotoday/">UroToday.com</a> @KidneyCAN <a href="/montypal/">Sumanta K. Pal, MD, FASCO</a>
jc (@jadchahoud) 's Twitter Profile Photo

🚨 Solid tumor CAR T -> RCC? At #ASCO25, we #SamerSrour, Sumanta K. Pal, MD, FASCO present updated results from the TRAVERSE study of off-the-shelf CD70 CAR T cell therapy (ALLO-316) in mRCC: ✅ 31% ORR in heavily pretreated ccRCC ✅ Durable responses up to 1 year Moffitt Cancer Center MD Anderson Cancer Center

🚨 Solid tumor CAR T -&gt; RCC?
At #ASCO25, we #SamerSrour, <a href="/montypal/">Sumanta K. Pal, MD, FASCO</a> present updated results from the TRAVERSE study of off-the-shelf CD70 CAR T cell therapy (ALLO-316) in mRCC:
✅ 31% ORR in heavily pretreated ccRCC
✅ Durable responses up to 1 year
 <a href="/MoffittNews/">Moffitt Cancer Center</a> <a href="/MDAndersonNews/">MD Anderson Cancer Center</a>
Moffitt Cancer Center (@moffittnews) 's Twitter Profile Photo

During #ASCO25, Jad Chahoud, MD (jc), joined Patrick Hwu, MD, (Dr. Patrick Hwu) to discuss the emerging kidney cancer research being presented at ASCO. #MoffittASCO25

Fawzi Abu Rous, MD (@fawziaburous) 's Twitter Profile Photo

🎙️ Excited to launch our new LungCancerRx 🫁💊 podcast in partnership with Oncology News Central this Friday, 6/13! We kick off with a powerful first episode featuring Jill Feldman from EGFR Resisters. Tune in on #AppleMusic and #Spotify. Don’t miss it! #LungCancer #Oncology #LCSM